---
figid: PMC9385299__ECAM2022-1612829.003
pmcid: PMC9385299
image_filename: ECAM2022-1612829.003.jpg
figure_link: /pmc/articles/PMC9385299/figure/fig3/
number: Figure 3
figure_title: ''
caption: 'PD3 treatment reduced (a) Eotaxin, (b) IL-4 , (c) IL-5, (d) IL-13 (e) IFN-γ,
  (f) serum OVA-specific IgE levels in BALF. PD3: Platycodin D3. Data were expressed
  as mean ± SD, n = 6. Compared with the control group, ★P < 0.05, ★★P < 0.01; Compared
  with the Asthma group #P < 0.05, ##P < 0.01.'
article_title: Protective Effects of Platycodin D3 on Airway Remodeling and Inflammation
  via Modulating MAPK/NF-κB Signaling Pathway in Asthma Mice.
citation: Feng Peng, et al. Evid Based Complement Alternat Med. 2022;2022:1612829.
year: '2022'

doi: 10.1155/2022/1612829
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
